Arteriosonde Blood Press. Mntr. (#1020)
by Roche Medical Electronics, Inc.
510(k) K761057
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK761057 | Date9 Dec 1976 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- DXN
- Device Class
- Class II
- Regulation
- 21 CFR Part 870.1130
- Advisory Committee
- Cardiovascular
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 26 Sep 2026
The Arteriosonde Blood Pressure Monitor (#1020) is a non-invasive medical device designed to measure blood pressure. It is classified under the System, Measurement, Blood-Pressure, Non-Invasive category and falls under the Cardiovascular medical specialty.
The device is supplied as a single-use unit and is intended for use in clinical settings. It is not sterilized and requires proper storage conditions. The device is regulated under FDA 510(k) clearance (K761057) and has been reviewed by the Cardiovascular Advisory Committee.
Other devices from Roche Medical Electronics, Inc.
Questions
AI-generated answers, 26 Sep 2026
What is the Arteriosonde Blood Pressure Monitor (#1020) used for?
The Arteriosonde Blood Pressure Monitor (#1020) is a non-invasive medical device designed to measure blood pressure in clinical settings.
Is the Arteriosonde Blood Pressure Monitor (#1020) sterile?
No, the device is not sterilized and requires proper storage conditions before use.
Is the Arteriosonde Blood Pressure Monitor (#1020) intended for single use?
Yes, the device is supplied as a single-use unit and is intended for use in clinical settings.
How is the Arteriosonde Blood Pressure Monitor (#1020) regulated?
The device is regulated under FDA 510(k) clearance (K761057) and has been reviewed by the Cardiovascular Advisory Committee.